This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Esserman, L. Articles by Sickles, E. Search for Related Content PubMed PubMed Citation Articles by Esserman, L. Articles by Sickles, E. Social Bookmarking                            What's this?

Utility of Magnetic Resonance Imaging in the Management of Breast Cancer: Evidence for Improved Preoperative Staging

From the Departments of Surgery, Radiology, and Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA 94143.

Address reprint requests to Laura J. Esserman, MD, MBA, Breast Care Center, UCSF/ Mount Zion Cancer Center, 2356 Sutter St, San Francisco, CA 94115–1714.

PURPOSE: The staging and treatment for breast cancer are changing; there is an increase in the incidence of ductal carcinoma-in-situ, the use of fine-needle aspiration and stereotactic biopsy for diagnosis, and the use of neoadjuvant chemotherapy. Thus, there is a need for a tool to assess more precisely the extent of cancer in the breast before surgery. To better plan surgical and chemotherapeutic interventions, we evaluated high-resolution magnetic resonance imaging (MRI) as such a tool.

PATIENTS AND METHODS: Fifty-seven patients with 58 cases of breast cancer were evaluated preoperatively with MRI using a technique called the triple-acquisition rapid gradient echo technique to maximize anatomic detail. Imaging results were compared with mammography and subsequent pathology results.

RESULTS: Magnetic resonance imaging correctly identified residual or primary cancer in 55 of 58 cases and accurately predicted the extent of the cancer in 54 of 58 cases. The anatomic extent was more accurately defined with MRI compared with mammography (98% v 55%). Magnetic resonance imaging added the greatest value in cases of multifocal disease.

CONCLUSION: By applying MRI selectively to patients with a known diagnosis of cancer and focusing on defining the extent of malignant lesions, we were able to obtain clear and accurate anatomic information. Our results suggest that MRI could provide very valuable information for preoperative planning and single-stage resection in breast cancer. Based on preliminary data from our series, MRI would be valuable as a staging tool in the preoperative setting even if the cost is in the range of $1,300 to $2,000. It is already significantly less than the target cost, so it is reasonable to refine this technique for clinical use to help plan the most appropriate surgical intervention and possibly reduce costs as well. A careful prospective study is warranted to validate our findings.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				L. ENRIQUEZ and J. LISTINSKY Role of MRI in breast cancer management Cleveland Clinic Journal of Medicine, September 1, 2009; 76(9): 525 - 532. [Abstract] [Full Text] [PDF]

				R. Katipamula, A. C. Degnim, T. Hoskin, J. C. Boughey, C. Loprinzi, C. S. Grant, K. R. Brandt, S. Pruthi, C. G. Chute, J. E. Olson, et al. Trends in Mastectomy Rates at the Mayo Clinic Rochester: Effect of Surgical Year and Preoperative Magnetic Resonance Imaging J. Clin. Oncol., September 1, 2009; 27(25): 4082 - 4088. [Abstract] [Full Text] [PDF]

				N. Houssami and D. F. Hayes Review of Preoperative Magnetic Resonance Imaging (MRI) in Breast Cancer: Should MRI Be Performed on All Women with Newly Diagnosed, Early Stage Breast Cancer? CA Cancer J Clin, September 1, 2009; 59(5): 290 - 302. [Abstract] [Full Text] [PDF]

				N. Houssami Overview of the Evidence on MRI-guided Local Staging of Breast Cancer and Effect on Treatment ASCO Educational Book, January 1, 2009; 2009(1): 45 - 50. [Abstract] [Full Text] [PDF]

				F. Pediconi, C. Catalano, S. Padula, A. Roselli, V. Dominelli, S. Cagioli, M. A. Kirchin, G. Pirovano, and R. Passariello Contrast-Enhanced MR Mammography: Improved Lesion Detection and Differentiation with Gadobenate Dimeglumine Am. J. Roentgenol., November 1, 2008; 191(5): 1339 - 1346. [Abstract] [Full Text] [PDF]

				M.-L. W. Ah-See, A. Makris, N. J. Taylor, M. Harrison, P. I. Richman, R. J. Burcombe, J. J. Stirling, J. A. d'Arcy, D. J. Collins, M. R. Pittam, et al. Early Changes in Functional Dynamic Magnetic Resonance Imaging Predict for Pathologic Response to Neoadjuvant Chemotherapy in Primary Breast Cancer Clin. Cancer Res., October 15, 2008; 14(20): 6580 - 6589. [Abstract] [Full Text] [PDF]

				N. Taira, S. Ohsumi, D. Takabatake, F. Hara, S. Takashima, K. Aogi, S. Takashima, T. Inoue, S. Sugata, and R. Nishimura Contrast-enhanced CT Evaluation of Clinically and Mammographically Occult Multiple Breast Tumors in Women with Unilateral Early Breast Cancer Jpn. J. Clin. Oncol., June 1, 2008; 38(6): 419 - 425. [Abstract] [Full Text] [PDF]

				S. Orel Who Should Have Breast Magnetic Resonance Imaging Evaluation? J. Clin. Oncol., February 10, 2008; 26(5): 703 - 711. [Abstract] [Full Text] [PDF]

				T. A. Buchholz, C. D. Lehman, J. R. Harris, B. A. Pockaj, N. Khouri, N. F. Hylton, M. J. Miller, T. Whelan, L. J. Pierce, L. J. Esserman, et al. Statement of the Science Concerning Locoregional Treatments After Preoperative Chemotherapy for Breast Cancer: A National Cancer Institute Conference J. Clin. Oncol., February 10, 2008; 26(5): 791 - 797. [Abstract] [Full Text] [PDF]

				M. Kaufmann, G. von Minckwitz, H. D. Bear, A. Buzdar, P. McGale, H. Bonnefoi, M. Colleoni, C. Denkert, W. Eiermann, R. Jackesz, et al. Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006 Ann. Onc., December 1, 2007; 18(12): 1927 - 1934. [Abstract] [Full Text] [PDF]

				D. J. Hsiang, M. Yamamoto, R. S. Mehta, M.-Y. Su, C. H. Baick, K. T. Lane, and J. A. Butler Predicting Nodal Status Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Patients With Locally Advanced Breast Cancer Undergoing Neoadjuvant Chemotherapy With and Without Sequential Trastuzumab Arch Surg, September 1, 2007; 142(9): 855 - 861. [Abstract] [Full Text] [PDF]

				C. C. Genson, C. E. Blane, M. A. Helvie, S. A. Waits, and T. L. Chenevert Effects on Breast MRI of Artifacts Caused by Metallic Tissue Marker Clips Am. J. Roentgenol., February 1, 2007; 188(2): 372 - 376. [Abstract] [Full Text] [PDF]

				L. J. Esserman, A. S. Kumar, A. F. Herrera, J. Leung, A. Au, Y.-Y. Chen, D. H. Moore, D. F. Chen, J. Hellawell, D. Wolverton, et al. Magnetic Resonance Imaging Captures the Biology of Ductal Carcinoma In Situ J. Clin. Oncol., October 1, 2006; 24(28): 4603 - 4610. [Abstract] [Full Text] [PDF]

				S. K. Shah, S. K. Shah, and K. V. Greatrex Current Role of Magnetic Resonance Imaging in Breast Imaging: A Primer for the Primary Care Physician J Am Board Fam Med, November 1, 2005; 18(6): 478 - 490. [Abstract] [Full Text] [PDF]

				S. C. Partridge, J. E. Gibbs, Y. Lu, L. J. Esserman, D. Tripathy, D. S. Wolverton, H. S. Rugo, E. S. Hwang, C. A. Ewing, and N. M. Hylton MRI Measurements of Breast Tumor Volume Predict Response to Neoadjuvant Chemotherapy and Recurrence-Free Survival Am. J. Roentgenol., June 1, 2005; 184(6): 1774 - 1781. [Abstract] [Full Text] [PDF]

				C. El Khoury, V. Servois, F. Thibault, A. Tardivon, L. Ollivier, M. Meunier, C. Allonier, and S. Neuenschwander MR Quantification of the Washout Changes in Breast Tumors Under Preoperative Chemotherapy: Feasibility and Preliminary Results Am. J. Roentgenol., May 1, 2005; 184(5): 1499 - 1504. [Abstract] [Full Text] [PDF]

				N. Hylton Magnetic Resonance Imaging of the Breast: Opportunities to Improve Breast Cancer Management J. Clin. Oncol., March 10, 2005; 23(8): 1678 - 1684. [Full Text] [PDF]

				G. Amano, M. Yajima, Y. Moroboshi, Y. Kuriya, and N. Ohuchi MRI Accurately Depicts Underlying DCIS in a Patient with Paget's Disease of the Breast Without Palpable Mass and Mammography Findings Jpn. J. Clin. Oncol., March 1, 2005; 35(3): 149 - 153. [Abstract] [Full Text] [PDF]

				J. I. Wiener, K. J. Schilling, C. Adami, and N. A. Obuchowski Assessment of Suspected Breast Cancer by MRI: A Prospective Clinical Trial Using a Combined Kinetic and Morphologic Analysis Am. J. Roentgenol., March 1, 2005; 184(3): 878 - 886. [Abstract] [Full Text] [PDF]

				H. Jin, Y. Lu, K. Stone, and D. M. Black Alternative Tree-Structured Survival Analysis Based on Variance of Survival Time Med Decis Making, November 1, 2004; 24(6): 670 - 680. [Abstract] [PDF]

				F. Sardanelli, G. M. Giuseppetti, P. Panizza, M. Bazzocchi, A. Fausto, G. Simonetti, V. Lattanzio, and A. Del Maschio Sensitivity of MRI Versus Mammography for Detecting Foci of Multifocal, Multicentric Breast Cancer in Fatty and Dense Breasts Using the Whole-Breast Pathologic Examination as a Gold Standard Am. J. Roentgenol., October 1, 2004; 183(4): 1149 - 1157. [Abstract] [Full Text] [PDF]

				F. Thibault, C. Nos, M. Meunier, C. El Khoury, L. Ollivier, B. Sigal-Zafrani, and K. Clough MRI for Surgical Planning in Patients with Breast Cancer Who Undergo Preoperative Chemotherapy Am. J. Roentgenol., October 1, 2004; 183(4): 1159 - 1168. [Abstract] [Full Text] [PDF]

				S. Komatsu, C. J. Lee, Y. Hosokawa, D. Ichikawa, T. Hamashima, K. Shirono, H. Okabe, H. Kurioka, and T. Oka Comparison of Intraductal Spread on Dynamic Contrast-enhanced MRI with Clinicopathologic Features in Breast Cancer Jpn. J. Clin. Oncol., September 1, 2004; 34(9): 515 - 518. [Abstract] [Full Text] [PDF]

				A. Luciani, T. H. Dao, M. Lapeyre, M. Schwarzinger, C. Debaecque, L. Lantieri, G. Revelon, M. Bouanane, H. Kobeiter, and A. Rahmouni Simultaneous Bilateral Breast and High-Resolution Axillary MRI of Patients with Breast Cancer: Preliminary Results Am. J. Roentgenol., April 1, 2004; 182(4): 1059 - 1067. [Abstract] [Full Text] [PDF]

				J. M. Lee, S. G. Orel, B. J. Czerniecki, L. J. Solin, and M. D. Schnall MRI Before Reexcision Surgery in Patients with Breast Cancer Am. J. Roentgenol., February 1, 2004; 182(2): 473 - 480. [Abstract] [Full Text] [PDF]

				E. L. Rosen, K. L. Blackwell, J. A. Baker, M. S. Soo, R. C. Bentley, D. Yu, T. V. Samulski, and M. W. Dewhirst Accuracy of MRI in the Detection of Residual Breast Cancer After Neoadjuvant Chemotherapy Am. J. Roentgenol., November 1, 2003; 181(5): 1275 - 1282. [Abstract] [Full Text] [PDF]

				D. E. March, B. F. Coughlin, R. B. Barham, R. A. Goulart, S. V. Klein, M. E. Bur, J. L. Frank, and G. Makari-Judson Breast Masses: Removal of All US Evidence during Biopsy by Using a Handheld Vacuum-assisted Device--Initial Experience Radiology, May 1, 2003; 227(2): 549 - 555. [Abstract] [Full Text] [PDF]

				L. Liberman, E. A. Morris, D. D. Dershaw, A. F. Abramson, and L. K. Tan MR Imaging of the Ipsilateral Breast in Women with Percutaneously Proven Breast Cancer Am. J. Roentgenol., April 1, 2003; 180(4): 901 - 910. [Abstract] [Full Text] [PDF]

				M. Dowsett Preoperative Models to Evaluate Endocrine Strategies for Breast Cancer Clin. Cancer Res., January 1, 2003; 9(1): 502s - 510s. [Abstract] [Full Text]

				S. C. Partridge, J. E. Gibbs, Y. Lu, L. J. Esserman, D. Sudilovsky, and N. M. Hylton Accuracy of MR Imaging for Revealing Residual Breast Cancer in Patients Who Have Undergone Neoadjuvant Chemotherapy Am. J. Roentgenol., November 1, 2002; 179(5): 1193 - 1199. [Abstract] [Full Text] [PDF]

				R. Katz-Brull, P. T. Lavin, and R. E. Lenkinski Clinical Utility of Proton Magnetic Resonance Spectroscopy in Characterizing Breast Lesions J Natl Cancer Inst, August 21, 2002; 94(16): 1197 - 1203. [Abstract] [Full Text] [PDF]

				G. F. Tillman, S. G. Orel, M. D. Schnall, D. J. Schultz, J. E. Tan, and L. J. Solin Effect of Breast Magnetic Resonance Imaging on the Clinical Management of Women With Early-Stage Breast Carcinoma J. Clin. Oncol., August 15, 2002; 20(16): 3413 - 3423. [Abstract] [Full Text] [PDF]

				W. K. Moon, D.-Y. Noh, and J.-G. Im Multifocal, Multicentric, and Contralateral Breast Cancers: Bilateral Whole-Breast US in the Preoperative Evaluation of Patients Radiology, August 1, 2002; 224(2): 569 - 576. [Abstract] [Full Text] [PDF]

				S. G. Orel and M. D. Schnall MR Imaging of the Breast for the Detection, Diagnosis, and Staging of Breast Cancer Radiology, July 1, 2001; 220(1): 13 - 30. [Abstract] [Full Text] [PDF]

				J. P. McGahan, S. M. Griffey, P. D. Schneider, J. M. Brock, C. D. Jones, and S. Zhan Radio-Frequency Electrocautery Ablation of Mammary Tissue in Swine Radiology, November 1, 2000; 217(2): 471 - 476. [Abstract] [Full Text]

				T. Nakamura, T. Fukutomi, H. Tsuda, S. Akashi-Tanaka, K. Matsuo, C. Shimizu, and K. Miyakawa Changes in Findings of Mammography, Ultrasonography and Contrast-enhanced Computed Tomography of Three Histological Complete Responders with Primary Breast Cancer Before and After Neoadjuvant Chemotherapy: Case Reports Jpn. J. Clin. Oncol., October 1, 2000; 30(10): 453 - 457. [Abstract] [Full Text] [PDF]